Identifying research priorities to assess climate change impacts on malaria and arboviruses in Sub-Saharan Africa: An International Planning Meeting
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 460418
Grant search
Key facts
Disease
Unspecified, Unspecified…Start & end year
2022Known Financial Commitments (USD)
$15,737.96Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Kulkarni Manisha A, Mosha Franklin W, Protopopoff NatachaResearch Location
TanzaniaLead Research Institution
Kilimanjaro Christian Medical University College (Tanzania)Research Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Post acute and long term health consequencesSpecial Interest Tags
N/AStudy Type
Not applicableClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
Climate change, alongside other global scale phenomena such as globalization and persisting social inequities, is driving an increase in global health risks from infectious disease outbreaks. Vector-borne diseases such as malaria, dengue, and other arthropod-borne viruses (arboviruses) are particularly sensitive to the effects of climate change. The goal of this project is to address identified global health research priorities and build upon the expertise of our research team to develop an innovative research program addressing climate change-driven impacts on malaria and arbovirus transmission in sub-Saharan Africa. The project will finance an international planning meeting to establish a multidisciplinary research agenda and further strengthen Canada's global health research expertise through the development of authentic global health research partnerships. The future research will directly benefit the health of people living in parts of sub-Saharan Africa that are experiencing climate change impacts, while indirectly benefiting the health of people in Canada through the early identification of emerging global disease threats.